Premium
Medication therapy management services in community pharmacy: a pilot programme in HIV specialty pharmacies
Author(s) -
Rosenquist Ashley,
Best Brookie M.,
Miller Teresa A.,
Gilmer Todd P.,
Hirsch Jan D.
Publication year - 2010
Publication title -
journal of evaluation in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.737
H-Index - 73
eISSN - 1365-2753
pISSN - 1356-1294
DOI - 10.1111/j.1365-2753.2009.01283.x
Subject(s) - pharmacy , medicine , pharmacist , medical prescription , specialty , family medicine , reimbursement , nursing , medication therapy management , health care , economics , economic growth
Rationale, aims and objectives Pharmacist‐provided medication therapy management services (MTMS) have been shown to increase patient's adherence to medications, improve health outcomes and reduce overall medical costs. The purpose of this study was to describe a pilot programme that provided pharmacy‐based MTMS for patients with HIV/AIDS in the state of California, USA. Method Pharmacists from the 10 pilot pharmacies were surveyed using an online data collection tool. Information was collected to describe the types of MTMS offered, proportion of patients actively using specific MTMS, pharmacist beliefs regarding effect on patient outcomes and barriers to providing MTMS, ability to offer MTMS without pilot programme funding and specialized pharmacist or staff training. Results Each responding pharmacy (7 of 10) varied in the number of HIV/AIDS patients served and prescription volume. All pharmacists had completed HIV/AIDS‐related continuing education programmes, and some had other advanced training. The type of MTMS being offered varied at each pharmacy with ‘individualized counselling by a pharmacist when overuse or underuse was detected’ and ‘refill reminders by telephone’ being actively used by the largest proportion of patients. Most, but not all, pharmacists cited reimbursement as a barrier to MTMS provision. Pharmacists believed the MTMS they provide resulted in improved satisfaction (patient and provider), medication usage, therapeutics response and patient quality of life. Conclusion The type of MTMS offered, and proportion of patients actively using, varied among participating pilot pharmacies. Pharmacists believed MTMS improved medication usage and patient outcomes, although availability of reimbursement to sustain MTMS was a concern. Further study of objective outcomes data is ongoing.